The activity of several enzymes has been determined in the livers of homozygous obese and adipose mice, their normal litter-mates, and phenocopies induced in normal mice by aurothioglucose (ATG) injections.
INTRODUCTION
Investigations of the control of metabolism are greatly aided if genetic variants affecting different steps in a pathway are available. In particular, if variation in the activity of an enzyme can be correlated with a change in concentration of metabolites and their flux through the pathway, an insight into the importance of specific steps can be obtained (Kacser & Burns, 1968) . While micro-organisms have been extensively used to obtain mutants of particular enzyme activities, there have been few attempts to screen for these in mammals. Feinstein and his colleagues (Feinstein et al. 1964 (Feinstein et al. , 1968 were successful with mice in discovering mutants of catalase by screening the progeny of irradiated males. However, most research on the genetics and metabolism in mice has been carried out with mutants that have been discovered by their gross visible effects. These include symptoms 52 G. BULFIELD such as early death, colour, severe neurological and balance defects and skeletal abnormalities. In hardly any of these is the site of the primary lesion known. Moreover little is known of the detailed metabolic consequences of these mutants.
In studying lipid metabolism the obese mutant, commonly referred to as the obese-hyperglycaemic syndrome, has been the subject of much research (Mayer, 1960; Jansen, Zanetti & Hutchison, 1967; Mayer & Thomas, 1967; Schreeve et al. 1967) . The primary alteration in gene product in this mutant is, however, not yet known. It is therefore of importance that Lowenstein and his colleagues (Kornaker & Lowenstein, 1964a; Spencer & Lowenstein 1966) have reported that ATP citrate lyase (citrate cleavage enzyme) has a threefold higher specific activity in obese mice than in their non-obese litter-mates. Kornaker & Lowenstein (1964) argued that, as this enzyme is the first one in the de novo synthesis of fatty acids, it could be 'rate controlling' for the pathway, implying that it may be the gene product of the obese locus.
The establishment that this or any other enzyme is the primary change would be valuable in the investigation and understanding of many biochemical and physiological effects of this syndrome. It is, however, not generally accepted that ATP citrate lyase enzyme is the 'rate-controlling step' in lipogenesis. Other enzymes have been investigated for their involvement in the control of de novo lipid synthesis from glucose (Wise & Ball, 1964; Lynen et al. 1964) . Therefore neither the involvement of the ob locus with any one enzyme nor the importance of such enzymes in the control of lipid metabolism have been established.
It was therefore thought necessary to investigate the activity of a variety of enzymes in the obese mutant and compare them with changes seen in ATP citrate lyase (10). The part of the metabolic map showing the enzymes discussed here is illustrated in Fig. 1 . The number after each enzyme refers to its position in this figure. The enzymes chosen were, from the malate transhydrogenation shunt, supernatant malic enzyme (7) and supernatant malate dehydrogenase (6); from glycolysis, pyruvate kinase (5) and lactate dehydrogenase (15); and from the TCA cycle, isocitrate dehydrogenase (8) and fumarase (9). Comparisons are also made with published data on the lipogenic enzymes (acetyl Co A carboxylase (11) and fatty-acid synthetase (12)) and some lipases (13).
Several enzymes were found to have altered activities in obese mice. It is difficult, however, to establish that an enzyme is the site of the primary lesion of a mutant when data are only available on its altered activity and no information on other kinetic or physical parameters. This problem is discussed in some detail and some criteria are proposed which may help to solve it.
GLC analyses of the lipids were made, since it was possible that the mutant differed in the type as well as the quantity of fatty acid.
The comparison of normal and obese animals was extended to two other types of obesity available. The first type is another mutant, adipose, discovered in this laboratory (Falconer & Isaacson, 1959) . In terms of obesity, adipose is indistinguishable from obese. They are, however, functionally non-allelic as the double heterozygote is normal. The linkage relationships of the two genes has not been Enzyme studies of obese and adipose mice 53 established and this is discussed below. The third type of obesity is a phenocopy induced in normal mice by aurothioglucose, (ATG), injections (Mayer, 1960) .
All three types of animal, obese, adipose and ATG, were found to have identical enzyme changes when compared with the normal although all three are genetically different. Furthermore it was found that not only ATP citrate lyase but also malic enzyme and pyruvate kinase showed an increase in activity.
These observations, together with the recessive nature of the two mutants, will be discussed in relation to the control of lipogenesis and the question of the site of gene action.
METHODS (i) Animals
The obese mice used were from a stock originally obtained from the Jackson Laboratory, Bar Harbor, U.S.A., and have been maintained at this laboratory for some time. The adipose mutation appeared in a stock at this laboratory (Falconer & Isaacson, 1959) .
(ii) Quantitative extraction of fat Mice were identified by inspection and killed at 6-10 weeks of age and chopped up with solvent in a Waring Blender. The chopped mouse was then washed into a large filter cup and renuxed gently in a Soxhlet for 12 h with diethylether. The dissolved lipid was washed with water, the ether evaporated, and weighed.
(iii) G.L.C. analysis of lipids Lipids were extracted as above and the triglycerides were separated by the method of Goodman, Deykin & Shiratori (1962) . The triglyceride was directly saponified with 10% KOH in methanol. Any contaminating non-saponifiables were removed with petroleum ether. The acqueous fraction was acidified with concentrated HC1 to pH 1-0, vortexed and extracted three times with petroleum ether. The pooled petroleum ether fractions were washed three times with water and dried over anhydrous sodium sulphate. The extract was concentrated by evaporation and methylated with the boron trifluoride/methanol complex (B.D.H.), which was then destroyed with water. The methylated fatty acids were extracted in petroleum ether and concentrated for gas-liquid chromatography.
(iv) Enzyme assays Mice were identified by inspection and killed at 6-10 weeks of age and a piece of liver immediately homogenized with 3 times (v/w) of freshly prepared 0-25M sucrose at 0-5 °C. Either the crude homogenate was used for the enzyme assay or the homogenate was centrifuged at 60000 g av for 1 h and the supernatant was used.
The enzyme assays used were based on the methods of the following authors ATP citrate lyase (EC 4.1.3.8) (10), Srere (1959) ; malic enzyme (EC 1.1.1.40) (7), Ochoa (1955c) ; malate dehydrogenase (EC 1.1.1.37) (6), Ochoa (19556) pyruvate kinase (EC 2.7.1.40) (5), Weber, Stamm & Fisher (1965) ; lactate dehydrogenase (EC 1.1.1.27) (15), Kornberg (1955) ; isocitrate dehydrogenase (EC 1.1.1.41) (8), Ochoa (1955a) and fumarase (EC 4.2.1.2) (9), Racker (1950) . Protein was determined by the method of Lowry et al. (1951) .
(v) Injection of aurothioglucose To destroy the ventromedial nucleii of the hypothalamus and induce phenocopies of obese and adipose, aurothioglucose was used (Marshall, Barnett & Mayer, 1954) . The aurothioglucose, in water, was injected at 1 mg/g body weight, intraperitoneally. This amount is a 50 % lethal dose. Dead animals were seen in 2-3 days and the survivors became noticeably fat in 2-4 weeks after injection (see Fig. 2 for an example of the growth of these mice). Table 1 shows that the adipose mutant has just as much extractable fat in its carcass as the obese mutant. Adipose was found to be slightly lighter than obese but this may be due to a difference in genetic background.
RESULTS (i) Live weight and percentage fat
(ii) Fatty-acid composition The relative amounts of the different fatty acids in fat tissue of obese mice had been determined (Stein, Anderson & Hollifield, 1967; Haessler & Crawford, 1965) but was not found to be significantly different from normal mice. In the present investigation no difference between obese, adipose and normal mice has been detected ( Table 2) . Therefore there is no alteration in the metabolism of obese and adipose mice which affects the type of fatty acid produced. The effects of the genetic alterations are therefore not concerned with the steps synthesizing specific fatty acids but must be concerned with the synthesis or breakdown of total lipids. Tables 3-9 show the results of determination of enzyme activity in obese, adipose, ATG and normal mice. Each table presents the results of within-litter comparisons for one enzyme. The ATG injections were made about 5-6 weeks of age after animals had been classified as normal (Fig. 2) . Since no attempt was made to 56 G. BlJLFIELD equalize the genetic background of the ad and ob carrying strain, slight differences between the normal values for these strains were observed, but these do not affect the conclusions which can be reached. For enzymes where a difference in activity was observed between the mutant and the normal, only two non-overlapping classes were found. These classes coincided with scoring done on the basis of 'fat' or 'normal' phenotypes. This is relevant to the discussion of dominance relationships in a later section. Table 3 shows that ATP citrate lyase (10), malic enzyme (7) and pyruvate kinase (5) activity fall into two classes. The activities of the enzymes were at a similar level in obese, adipose and ATG when compared with normal litter-mates. However, the activities of malate dehydrogenase (6), lactate dehydrogenase (15), isocitrate dehydrogenase (8) and fumarase (9) showed no difference between litter-mates (Table 3) . + 0-10 + 0-14 ± 0-07 0-60***+ 0-07 0-44 0-16 8-6** 6-4*** 2-2 6-3*** 11-1*** )4-8*** 6-0** 5-9* 0-1 3-7** 3-1** 0-6 45 14 31 5-0 7-0 odipose-ATG ( -)2-0 o&ese-normal -adipose-normal -o&ese-normal ( --adipose-normal -o&ese-normal -adipose-normal -P < 0-001. The activities in ATG-treated mice were indistinguishable from either obese or adipose for those enzymes which showed higher activities. Similarly, for an enzyme unaffected by the genotype (MDH) no alteration in activity was observed for the ATG treated mice. There is no reason to believe that the other enzymes shown in Table 3 for which no ATG valves are available would have behaved any differently. available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0016672300013586 58 G. BULFIELD It therefore appears that the ATG phenocopies mimic the mutants at the level of enzyme activity as well as by their physical appearance.
(iii) Enzyme activities

(iv) Dominance relationships
Where the activity of an enzyme had been altered only two activity classes were found. This clearly means that dominance is shown at the enzyme level. Therefore a ratio of 3:1 is expected in offspring from a heterozygous mating. This was tested in a larger scale experiment with ATP citrate lyase (10) activity. The observed ratio of normal: high was 72:23 in litters from the ob/+ cross and was 43:13 in litters from the adj+ cross. Neither of these ratios is significantly different from 3:1. The absence of an intermediate enzyme activity class -that is, recessivity at the enzyme level -is a significant observation relevant to the question of primary gene action. This lack of a gene dosage effect will be dealt with in the discussion.
(v) The relationship between ob and ad The genes ob and ad are non-allelic, Falconer & Isaacson (1959) having found no mutant phenotypes in 72 progeny from test crosses between proved ad heterozygotes and proved ob heterozygotes. The two genes may therefore code for different gene products. However, ad and ob may be in the same structural gene (and hence very closely linked), but may complement each other.
In all cases the activity of the enzymes in obese and adipose differed only slightly from each other. These slight differences were probably due to ob and ad having arisen in different strains. No attempt was made to cross these genes into the same background. The slight enzyme differences, however, became undetectable in the breeding programme aimed at producing double mutants when genetic backgrounds tended to be equalized.
Three matings were constructed where both the male and female had been progeny tested and were known to be heterozygotes for both the ad and ob genes. In genetical nomenclature the matings were ob ad " ob ad _ _ There were 66 offspring from these matings which fell into two-non-overlapping classes, 31 being 'normal' and 35 'fat'; these classes coincided for both physical appearance and ATP citrate-lyase activity (Fig. 3) . If the genes are closely linked they would be present in the above matings hi repulsion. Therefore a ratio of 1:1, normal:fat, would be expected among the 66 progeny. The observed ratio of 31:35, tested against this expectation, gives a ^2 = 1-24 with P = 0-5, and therefore the data are consistent with close linkage.
If ad and ob are not linked we have different expectations. The products of the two genes may interact -that is, the gene dosage at one locus may influence the expression of the other. For although it is known that the double heterozygote is 'normal' because the parents were of this genotype is not known. Any of these phenotypes may be prenatal lethal, normal, fat or 'superfat'. No 'superfat' animals appeared in these 66 progeny and the most reasonable assumption to make is that the three unknown genotypes are all fat. In that case, the assumption of no linkage would predict a digenic ratio of 9 normal: 7 fat. The observed ratio of 31:35 tested against this expectation gives a X60 G. BlTLFIELD There is no alteration in the activity of four enzymes in obese adipose and, where determined, ATG mice, whereas there is a higher level of three others (Table 3) . Other workers have determined the activity of several other enzymes in obese but not in adipose and these are shown in Table 4 . So altogether eight enzymes have much higher activities in obese, four enzymes have slightly elevated activities and six enzymes have unaltered activities. Where the activity has been altered in obese only two classes of activity are reported for obese and their normal litter-mates. There is therefore no gene dosage affect at the level of the activity of these enzymes.
Two further enzymes have been investigated in obese, namely hormone-sensitive lipase (Lochaya, Hamilton & Mayer, 1963) and 2-monoglyceride lipase (Stein et al. 1967) (13) . Contrary to the behaviour of all other investigated enzymes, both these show lowered activity in the obese mutant.
Glucose oxidation is another phenotype with lowered values in obese. It has further been reported that the fat pads from the obese heterozygote has intermediate rates of glucose oxidation, although no information was given on any of the enzymes involved (Yen, Lowry & Steinmitz, 1968) .
As described in the Methods section, physical phenocopies of the obese and adipose can be induced by aurothioglucose injections. These ATG mice are known to be, in part, physiologically different from obese (Mayer, 1960) . In terms of enzyme pattern, however, they are very similar to the mutants and therefore a different biochemical lesion induces the same complex enzyme pattern. The observed enzyme pattern therefore appears to be a secondary phenomenon. A further interesting aspect of these observations is that there appears to be no simple pattern in the distribution of 'affected' and 'non-affected' enzymes. Thus both classes occur in gluconeogenesis as well as in glycolysis. Both enzymes in lipogenesis are elevated. The primary effect in both mutants and the lesion in the phenocopy therefore has widespread consequences.
Before this investigation was started it had been reported (Kornaker & Lowenstein, 1964a; Spencer & Lowenstein, 1966) that obese mice had a higher ATP citrate lyase activity. This could be interpreted to mean that the enzyme might be the site of the primary lesion, although the evidence from obese (and partly from adipose and ATG) that 12 enzymes show elevated activities makes it unlikely (although not impossible) that the primary alteration is in one of them.
Although the primary lesion could be at a regulatory step rather than in an enzyme, it is useful to discuss, in the absence of structural data, other criteria that can be applied to a situation like the present one, in which there have been changes in the activity of several enzymes. There are three criteria that may be used to establish from alterations in activity whether an enzyme is the site of a mutant gene's action. Although each of them is not solely decisive, they can at least together be used to devise fairly firm conclusions. The criteria are:
(i) The allelic criterion In the case of two functionally allelic genes the problem is only to find the enzyme with altered structure or kinetic parameters. When two genes are functionally non-allelic (as in the case of ob and ad), if the two mutations are in two structural genes, it should be possible to pinpoint a separate altered enzyme for each mutant. However, the two mutants may affect different polypeptides in the same enzyme and therefore only one enzyme will be affected. Alternatively, they may be complementing alleles at one locus, and the primary effect may be similar for both genes. The observations that the same enzyme pattern appears in both mutants makes this criterion inapplicable in the present case.
(ii) The dosage criterion In cases where the gene-enzyme relationship has been established, dominance at some phenotypic level has always been shown to be associated with intermediate values at the enzyme level. The finding of intermediate values in heterozygotes is therefore a criterion that the locus involved controls the enzyme measured. This has been shown, for example, in the many human inborn errors of metabolism whose primary enzymic lesion is known (Harris, 1970, pp. 174-175 62 G. BULFIELD examined in the present investigation makes it unlikely that the ad or ob locus is directly concerned with the structural genes for any of these enzymes.
The obverse statement, that the presence of an intermediate class of enzyme activity in heterozygotes constitutes unambiguous evidence of the primary geneenzyme relationship, is not true. It is possible that one gene product can change the activity of several enzymes in the heterozygote to an intermediate level.
(iii) The recessivity criterion From much work on auxotrophs in micro-organisms, the study of inborn errors in man where the enzymic lesion is known, and from general consideration about the kinetic properties of multi-enzyme systems, we expect that a recessive structural allele will correspond to lower activity at the enzyme level. In obese and adipose, all enzymes altered had higher activity in the recessive homozygote. This argues against any of the 12 enzymes being primarily affected by the loci in question.
It may be concluded that none of the enzymes so far examined fulfil all the above three criteria in either the obese or the adipose mutants. However, of all the metabolic data published on obese only two alterations fulfil any of the criteria. The hormone-sensitive lipase (Lochaya et al. 1963 ) and 2-monoglyceride lipase (Stein et al. 1967) have lower activity in obese than normal and therefore fulfil criterion no. (iii); the intermediate rate of glucose oxidation by obese heterozygotes fulfils criterion no. (ii). It is not known whether these two sets of observations fulfil other criteria and they require closer investigation. Should the site of primary gene action be found, the problem of the elevation of a large number of other enzymes as secondary consequences would remain to be elucidated.
Lowenstein and his co-workers have also established that ATP citrate lyase activity correlates with lipogenesis under different nutritional and hormonal conditions as well as in the obese mouse (Kornaker & Lowenstein, 19646, 1965a, b) . They suggest that this might be the 'rate controlling' enzyme with respect to lipogenesis. ' Rate control' is often investigated in mammals by altering nutritional and hormonal conditions and recording correlated responses of enzymes, a response being thought of as consistent with rate control. However, in the obese, adipose and ATG mouse many enzymes are altered simultaneously. This would seem to indicate the hardly acceptable conclusion that all these enzymes are 'rate controlling 5 . With so many parameters altered in complex syndromes like obese and adipose it appears impossible to evaluate the 'rate controlling' properties of any enzyme. To simplify this problem Kacser & Burns (1968 and 1972) have developed a ' sensitivity coefficient' of flux to enzyme activity, which can be established for each enzyme using mutants in micro-organisms where the lesion is known and affects the activity of one enzyme.
